As the costs of medical education continue to rise, the National Institutes of Health Loan Repayment Programs (LRPs) serve as a lifeline for physician scientists who have high educational debt.
Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disorders. With support from the National Institutes of Health, researchers found those mutations through whole exome sequencing — a new gene scanning technology that cuts the cost and time of searching for rare mutations.
National Institutes of Health Director Francis S. Collins, M.D., Ph.D., today announced the appointment of Lawrence A. Tabak, D.D.S., Ph.D., as principal deputy director of the National Institutes of Health.
A major research effort to develop medical products to diagnose, prevent and treat the short- and long-term consequences of radiation exposure after a radiological or nuclear terrorist attack has been renewed today by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
People with a particular kind of knee alignment have a greater chance of developing osteoarthritis than do those with other types of leg alignment, reported researchers supported by the National Institutes of Health.
A regulatory protein best known for its role in a rare genetic brain disorder also may play a critical role in cocaine addiction, according to a recent study in rats, funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health.
A study by researchers at the National Institutes of Health and the University of Oxford supports the widespread belief that stress may reduce a woman’s chance of becoming pregnant.
Researchers supported by the National Institutes of Health have for the first time activated mouse egg cells at the earliest stage of their development and brought them to maturity. In a related experiment, the researchers replicated the finding by also bringing human eggs to maturity in the laboratory.
Antonello Bonci, M.D., one of the world’s leading researchers in neuropsychopharmacology, has been appointed the Scientific Director of National Institute on Drug Abuse’s (NIDA) Intramural Research Program (IRP) in Baltimore.
National Institutes of Health Director Francis S. Collins, M.D., Ph.D., announced today the appointment of Robert M. Kaplan, Ph.D., as Director, Office of Behavioral and Social Sciences Research (OBSSR) and NIH Associate Director for Behavioral and Social Sciences Research
